Previous 10 | Next 10 |
NetEase Showcases a Diverse Slate of Presentations at GDC 2023 PR Newswire Over 20 NetEase Games experts have been shortlisted to present at GDC this year, delivering more than 16 talks across the Core Concepts and Summits sessions. Presentations from NetEase Games session...
2023-03-15 11:26:09 ET Chinese tech companies' shares largely slumped Wednesday, with the likes of Alibaba ( NYSE: BABA ), JD.com ( NASDAQ: JD ) and Tencent Holdings ( OTCPK:TCEHY ) going into the red amid a broad-market retreat fueled by more uncertainty coming from...
2023-03-08 14:02:02 ET Chinese tech stocks put in a mildly negative performance Wednesday as Wall Street awaited the quarterly results from Internet retailing giant JD.com ( NASDAQ: JD ). Analysts currently estimate that JD ( JD ) will report a profit of 50 cents a sha...
2023-03-06 12:40:15 ET Chinese tech stocks put in a mixed performance Monday to start the week, amid reports that business between graphics chipmaker Nvidia ( NASDAQ: NVDA ) and Chinese tech giant Huawei could be on the rocks. Prior to the start of trading, a report from Reu...
NetEase ( NASDAQ: NTES ) is up 6.3% out of Wednesday's stock market open as J.P. Morgan upgraded the game maker to Overweight from Neutral, seeing a buying opportunity in a new game launch cycle. The stock is down 8%-plus since its fourth-quarter report alongside some profit-t...
Alibaba ( NYSE: BABA ) and Baidu ( NASDAQ: BIDU ) were among the biggest gaining Chinese tech stocks on Wednesday after economic data pointed to a recovery. China's official manufacturing purchasing managers index came in at a reading of 52.6, while the Caixin PMI rose to 51.6...
Summary NetEase's revenue rose 4% to 25.4 billion yuan in last year's fourth quarter, with 75% of that coming from its core gaming business. The company expects its Youdao education and Cloud Music units to break even in the next one to two years, following strong revenue growth last ye...
Reata Pharmaceuticals ( RETA ) +175% Pharmaceuticals up 192% on Friedreich's ataxia drug omaveloxolone approval. OncoSec Medical ( ONCS ) +94% . Lionheart III ( LION ) +53% . Sarepta Therapeutics ( SRPT ) +15% gains 18% as Morgan Stanley u...
Summary My most important takeaway from NetEase's Q4 FY22 earnings call yesterday is on the margin dynamics: The headline ~300bps gross profit margin miss vs consensus is understandable as it is due to a one-time effect. But a favorable mix effect toward PC games - which have materi...
NetEase, Inc. (NTES) Q4 2022 Earnings Conference Call Feb 23, 2023, 07:00 AM ET Company Participants Margaret Shi - Director of IR Charles Yang - CFO William Ding - CEO Conference Call Participants Alicia Yap - Citigroup Yang Bai - CICC Lincoln Kong...
News, Short Squeeze, Breakout and More Instantly...
2024-07-23 12:46:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
NetEase Cloud Music Partners with Timbaland's Beatclub™ to Revolutionise China's Beat Marketplace PR Newswire HANGZHOU, China , July 17, 2024 /PRNewswire/ -- Cloud Music Inc. (HKEX: 9899, "NetEase Cloud Music" or the "Company"), a leading interactive ...
2024-07-03 11:34:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...